Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|August 26, 2016
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivoTali Voloshin, Mijal Munster, Roni Blatt, et al.
Cancers|June 24, 2022
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In VivoShiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Cancers|February 25, 2023
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, et al.
Frontiers in Oncology|July 12, 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistanceYani Berckmans, Hila M Ene, Kerem Ben-Meir, et al.
Frontiers in Oncology|March 25, 2026
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cellsHila Fishman, Hila M Ene, Einav Zeevi, et al.
International Journal of Molecular Sciences|November 26, 2022
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo ModelYiftah Barsheshet, Tali Voloshin, Boris Brant, et al.
Molecular Cancer Therapeutics|June 30, 2025
Cancer Cell Permeability Induced by Tumor Treating Fields (TTFields) as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug ResistanceBella Koltun, Tali Voloshin, Cfir David, et al.
Frontiers in Microbiology|December 14, 2023
Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical studyAvraham Abutbul, Helena Mumblat, Yaara Porat, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical modelsHelena Mumblat, Antonia Martinez-Conde, Ori Braten, et al.
Cell Death Discovery|July 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)Kerem Wainer-Katsir, Adi Haber, Hila Fishman, et al.
Pageof 4